Leverage Shares -3x Short Moderna (MRNA) ETP Securities MRNS reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Leverage Shares -3x Short Moderna (MRNA) ETP Securities missed estimated earnings by -19.0%, reporting an EPS of $-0.74 versus an estimate of $-0.62.
Revenue was up $28 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 6.0% increase in the share price the next day.
Here's a look at Leverage Shares -3x Short Moderna (MRNA) ETP Securities's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.66 | -0.72 | -0.72 | -0.70 |
| EPS Actual | -0.61 | -0.61 | -0.67 | -0.76 |
| Revenue Estimate | 6.33M | 5.73M | 5.88M | 5.35M |
| Revenue Actual | 7.34M | 6.08M | 10.38M | 7.16M |
To track all earnings releases for Leverage Shares -3x Short Moderna (MRNA) ETP Securities visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
